Manfred Welslau
- Oncology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Pathology and Forensic Medicine top 0.5%
- Genetics top 0.5%
- Co-authors
- Véronique DièrasDavid MilesIan E. KropMark D. PegramLuca GianniSunil VermaEllie GuardinoKim T. Blackwell
- Topics
- HER2/EGFR in Cancer Research (17 papers)Advanced Breast Cancer Therapies (16 papers)Lymphoma Diagnosis and Treatment (15 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Manfred Welslau
70 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 4.1k
- Radiology, Nuclear Medicine and Imaging 1.6k
- Pulmonary and Respiratory Medicine 1.5k
- Pathology and Forensic Medicine 1.4k
- Genetics 1.2k
Countries citing papers authored by Manfred Welslau
This map shows the geographic impact of Manfred Welslau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Welslau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Welslau more than expected).
Fields of papers citing papers by Manfred Welslau
This network shows the impact of papers produced by Manfred Welslau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Welslau. The network helps show where Manfred Welslau may publish in the future.
Co-authorship network of co-authors of Manfred Welslau
This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Welslau. A scholar is included among the top collaborators of Manfred Welslau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Welslau. Manfred Welslau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 10 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 9 | |
| 8 | 15 | |
| 9 | 1 | |
| 10 | 24 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 110 | |
| 14 | 13 | |
| 15 | 15 | |
| 16 | 286 | |
| 17 | 90 | |
| 18 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trialbreakdown → | 962 |
| 19 | Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancerbreakdown → | 2665 |
| 20 | 2 |
About Manfred Welslau
Manfred Welslau is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 5.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (17 papers), Advanced Breast Cancer Therapies (16 papers) and Lymphoma Diagnosis and Treatment (15 papers). The work is most often cited by research in Oncology (4.1k citations), Genetics (1.2k citations) and Pathology and Forensic Medicine (1.4k citations). Manfred Welslau has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Véronique Dièras, David Miles, Ian E. Krop, Mark D. Pegram, Luca Gianni, Sunil Verma, Ellie Guardino, Kim T. Blackwell, Fang Ting Liang and Steven R. Olsen. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.